CMS Opens NCD For Boston Scientific’s Wingspan Intracranial Stent
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Wingspan brain vessel stent could become the first device approved under a humanitarian device exemption to receive national coverage
You may also be interested in...
CMS Suggests Noncoverage of Boston Sci Wingspan, Except In Clinical Trials
Boston Scientific's Wingspan intracranial stent would not be covered by Medicare except during FDA-cleared clinical trials, according to a 1CMS proposed rule issued Aug. 9
CMS Suggests Noncoverage of Boston Sci Wingspan, Except In Clinical Trials
Boston Scientific's Wingspan intracranial stent would not be covered by Medicare except during FDA-cleared clinical trials, according to a 1CMS proposed rule issued Aug. 9
Boston Scientific Finds Physician Support For Wingspan Brain Stent Coverage
Boston Scientific assures CMS that there is minimal risk in granting national coverage for its Wingspan brain vessel stent due to safeguards associated with the product's humanitarian device exemption